Innovation

Are deep learning models exponentially more efficient than conventional models in learning complex patterns from DNA sequencing data?

No items found.

A pilot study utilizing 4174 samples from The Cancer Genome Atlas (#TCGA) has published results of a 77.6% accuracy in predicting cancer types using the raw tumor sequences that integrate all somatic mutations and germline variants.

The authors attempt to compare their own method to other conventional cancer classification methods and try to benchmark results. The baseline was calculated using logistic penalized linear regression and linear support vector machines (widely known methods for cancer classification). Gradient Boosting Decision Tree (GBDT) and Multiple Layer Perceptron (MLP) models were also evaluated.

At MNM, quality and high performance are our driving forces. Therefore, we are developing artificial intelligence methodologies, such as gene convolutional autoencoders and the random similarity forest, to address the AI 'black box' problem, so that our models are interpretable and explainable.

Are deep learning models exponentially more efficient than conventional models in learning complex patterns from DNA sequencing data?
September 9, 2022

You may also like

We simplify the functioning of genomics pipelines

The roots of MNM go back to the world of science, where sharing knowledge is essential.

$100 Human Genome – is that finally possible?

More than twenty years after having the first sequenced human genome, the price of such service had fallen from billions of dollars to just $1000. But that’s not enough!

What do we know about somatic noncoding mutation patterns in cancer?

Over the last couple of years, scientists were able to identify many somatic driver mutations in protein-coding regions of the genome. This part of DNA comprises only 2% of the human genome. What about the remaining 98%?

How ARETEai platform can change the approach to drug discovery?

ARETEai platform is an important step in finding common ground for different experts working towards a single goal - better outcomes of personalized medicine.